106
Participants
Start Date
May 31, 2011
Primary Completion Date
January 31, 2013
Study Completion Date
February 28, 2015
E/C/F/TDF
E/C/F/TDF (150/150/200/300 mg) STR administered orally once daily
COBI
COBI 150 mg tablet administered with food orally once daily
ATV
ATV 300 mg tablet administered orally once daily
DRV
DRV 800 mg tablet administered orally once daily
NRTI
Participants will receive 2 investigator-selected NRTIs, which may include abacavir (ABC), lamivudine (3TC)/zidovudine (ZDV), didanosine (DDI), emtricitabine (FTC), ABC/3TC, 3TC, tenofovir disoproxil fumarate (TDF), or FTC/TDF, administered according to prescribing information.
Otto Wagner Spital, Vienna
Taylor Square Private Clinic, Darlinghurst
Holdsworth House Medical Practice, Sydney
Infectious Diseases Unit - The Alfred Hospital, Melbourne
Landeskrankenhaus Graz West, Graz
Chelsea Village Medical, New York
Mount Sinai Downtown Comprehensive Health Program, New York
North Shore University Hospital, Manhasset
AIDS Care, Rochester
Whitman Walker Clinic, Washington D.C.
Medical Faculty Associates, Washington D.C.
Carolinas Medical Center, Charlotte
Infectious Disease Specialists of Atlanta, Decatur
Mercer University/ Mercer Medicine Clinical Research, Macon
Orlando Immunology Center, Orlando
IDOCF/ValueHealthMD, LLC, Orlando
Therafirst Medical Center, Fort Lauderdale
Broward Health, Fort Lauderdale
Gary J. Richmond.M.D.,P.A., Fort Lauderdale
Midway Immunology and Research Center, Ft. Pierce
Center for HIV and Hepatogastroenterology, Düsseldorf
"Hospital Civil de Guadalajara Fray Antonio Alcalde", Guadalajara
Northstar Medical Center, Chicago
Central West Clinical Research, Inc., St Louis
Health for Life Clinic, Little Rock
Southwest Infectious Disease Clinical Research, Inc., Addison
Tarrant County Infectious Disease Associates, Fort Worth
Therapeutic Concepts, PA, Houston
National Jewish Health, Denver
Spectrum Medical Group, Phoenix
Kaiser Permanente, Los Angeles
Peter J. Ruane, M.D., Inc., Los Angeles
Anthony Mills, MD, Inc., Los Angeles
AHF Research Center, Beverly Hills
Orange Coast Medical Group, Newport Beach
Metropolis Medical, San Francisco
East Bay AIDS Center, Oakland
Instituto Dominicano de Estudio Virologicos, Santo Domingo
University of California, Davis, Sacramento
The Research Institute, Springfield
Yale University School of Medicine AIDS Program, New Haven
ID Care, Hillsborough
Sunnybrook Health Sciences Center, Toronto
Clinique Medicale du Quartier Latin, Montreal
Clinical Research Puerto Rico, San Juan
HOPE Clinical Research, San Juan
Brighton and Sussex University Hospitals NHS Trust, Brighton
Barts & the London NHS Trust, London
Homerton University Hospital, London
Guy's King's and St. Thomas' School of Medicine, London
St Stephen's AIDS Trust, London
Lead Sponsor
Gilead Sciences
INDUSTRY